The Aplastic Anemia and MDS International Foundation joined 156 other members of the Defense Health Research Consortium (DHRC) in calling for Congress to restore funding in Fiscal Year 2025 for the Congressionally Directed Medical Research Program (CDMRP) which includes the Bone Marrow Failure Research Program. AAMDSIF and the Consortium Members also called on Congress to increase funding for research through the CDMRP in Fiscal Year 2026 to approximately $123 million. Restoring this funding will help ensure that our country is prepared to meet current and future public health-related threats and challenges to our national security. Read how funding for these programs are relevant to national security, military families and our Bone Marrow Failure community.
Below are the letters to the Members of Congress as well as the full text of the health conditions included in CDMRP research.
| Attachment | Size |
|---|---|
 FY26 Defense Health Research letter-House-5.19.pdf | 142.47 KB |
| FY26 Defense Health Research letter-Senate_5.19.pdf | 142.3 KB |
| 2025 Defense Health Research Military Relevance with footnotes5.19.pdf | 487.15 KB |